Ruella, M., Barrett, D. M., Kenderian, S. S., Shestova, O., Hofmann, T. J., Scholler, J., . . . Gill, S. (2015). Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. J Immunother Cancer.
Style de citation ChicagoRuella, Marco, et al. "Treatment of Leukemia Antigen-loss Relapses Occurring After CD19-targeted Immunotherapies By Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells." J Immunother Cancer 2015.
Style de citation MLARuella, Marco, et al. "Treatment of Leukemia Antigen-loss Relapses Occurring After CD19-targeted Immunotherapies By Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells." J Immunother Cancer 2015.